blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3134099

EP3134099 - ANTI-CANDIDA COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.10.2020
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  15.11.2019
FormerGrant of patent is intended
Status updated on  11.07.2019
FormerExamination is in progress
Status updated on  25.08.2017
FormerRequest for examination was made
Status updated on  27.01.2017
FormerThe international publication has been made
Status updated on  16.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
PharmAlp SA
Route des Eterpys 22
1964 Conthey / CH
[2017/09]
Inventor(s)01 / MEUWLY, Philippe
Chemin des Sapins 4
CH-1170 Aubonne / CH
02 / ABBET, Christian
Rte du Chablais 16
CH-1869 Massongex / CH
03 / SCHNYDER, Bruno
Rue Pirazilina 15
CH-3963 Crans / CH
04 / DENIS, Jean-Martin
Route Cantonale 33
CH-1964 Conthey / CH
05 / SIMONNET, Xavier
Chemin du Verdan 14
CH-1926 Fully / CH
 [2017/09]
Representative(s)reuteler & cie SA
Chemin de la Vuarpillière 29
1260 Nyon / CH
[2017/09]
Application number, filing date15725418.623.04.2015
[2017/09]
WO2015IB52963
Priority number, dateEP2014016572924.04.2014         Original published format: EP 14165729
[2017/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015162579
Date:29.10.2015
Language:EN
[2015/43]
Type: A1 Application with search report 
No.:EP3134099
Date:01.03.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 29.10.2015 takes the place of the publication of the European patent application.
[2017/09]
Type: B1 Patent specification 
No.:EP3134099
Date:18.12.2019
Language:EN
[2019/51]
Search report(s)International search report - published on:EP29.10.2015
ClassificationIPC:A61K36/185, A61P31/00
[2017/09]
CPC:
A61K36/185 (EP,US); A61K35/741 (US); A61K36/282 (EP,US);
A61K9/0034 (EP,US); A61K9/0053 (US); A61K9/08 (US);
A61P31/00 (EP); A61K2035/115 (US); A61K2236/00 (EP,US);
A61K2236/333 (US); A61K2236/51 (US); A61K2236/53 (US) (-)
C-Set:
A61K36/185, A61K2300/00 (EP,US);
A61K36/282, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/09]
Extension statesBA25.10.2016
ME25.10.2016
Validation statesMANot yet paid
TitleGerman:ANTI-CANDIDA-ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON[2017/09]
English:ANTI-CANDIDA COMPOSITIONS AND USES THEREOF[2017/09]
French:COMPOSITIONS ANTI-CANDIDA ET LEURS UTILISATIONS[2017/09]
Entry into regional phase25.10.2016National basic fee paid 
25.10.2016Designation fee(s) paid 
25.10.2016Examination fee paid 
Examination procedure25.10.2016Examination requested  [2017/09]
25.10.2016Date on which the examining division has become responsible
18.05.2017Amendment by applicant (claims and/or description)
24.08.2017Despatch of a communication from the examining division (Time limit: M04)
13.12.2017Reply to a communication from the examining division
19.01.2018Despatch of a communication from the examining division (Time limit: M06)
18.07.2018Reply to a communication from the examining division
12.11.2018Despatch of a communication from the examining division (Time limit: M06)
10.05.2019Reply to a communication from the examining division
12.07.2019Communication of intention to grant the patent
08.11.2019Fee for grant paid
08.11.2019Fee for publishing/printing paid
08.11.2019Receipt of the translation of the claim(s)
Opposition(s)21.09.2020No opposition filed within time limit [2020/48]
Fees paidRenewal fee
26.04.2017Renewal fee patent year 03
20.04.2018Renewal fee patent year 04
22.03.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.04.2015
AL18.12.2019
AT18.12.2019
CY18.12.2019
CZ18.12.2019
DK18.12.2019
EE18.12.2019
ES18.12.2019
FI18.12.2019
HR18.12.2019
IT18.12.2019
LT18.12.2019
LV18.12.2019
MK18.12.2019
NL18.12.2019
PL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
SI18.12.2019
SK18.12.2019
SM18.12.2019
TR18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
IS18.04.2020
PT13.05.2020
[2022/32]
Former [2022/27]HU23.04.2015
AL18.12.2019
AT18.12.2019
CY18.12.2019
CZ18.12.2019
DK18.12.2019
EE18.12.2019
ES18.12.2019
FI18.12.2019
HR18.12.2019
IT18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
PL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
SI18.12.2019
SK18.12.2019
SM18.12.2019
TR18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
IS18.04.2020
PT13.05.2020
Former [2021/10]AL18.12.2019
AT18.12.2019
CZ18.12.2019
DK18.12.2019
EE18.12.2019
ES18.12.2019
FI18.12.2019
HR18.12.2019
IT18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
PL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
SI18.12.2019
SK18.12.2019
SM18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
IS18.04.2020
PT13.05.2020
Former [2020/51]AL18.12.2019
AT18.12.2019
CZ18.12.2019
DK18.12.2019
EE18.12.2019
ES18.12.2019
FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
SI18.12.2019
SK18.12.2019
SM18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
IS18.04.2020
PT13.05.2020
Former [2020/47]AL18.12.2019
CZ18.12.2019
DK18.12.2019
EE18.12.2019
ES18.12.2019
FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
SK18.12.2019
SM18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
IS18.04.2020
PT13.05.2020
Former [2020/40]AL18.12.2019
CZ18.12.2019
EE18.12.2019
FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
SK18.12.2019
SM18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
IS18.04.2020
PT13.05.2020
Former [2020/37]AL18.12.2019
CZ18.12.2019
EE18.12.2019
FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
SK18.12.2019
SM18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
PT13.05.2020
Former [2020/36]AL18.12.2019
CZ18.12.2019
EE18.12.2019
FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
PT13.05.2020
Former [2020/35]AL18.12.2019
CZ18.12.2019
FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
RO18.12.2019
RS18.12.2019
SE18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
Former [2020/32]AL18.12.2019
FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
NL18.12.2019
RS18.12.2019
SE18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
Former [2020/25]FI18.12.2019
HR18.12.2019
LT18.12.2019
LV18.12.2019
RS18.12.2019
SE18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
Former [2020/23]FI18.12.2019
LT18.12.2019
LV18.12.2019
SE18.12.2019
BG18.03.2020
NO18.03.2020
GR19.03.2020
Former [2020/22]FI18.12.2019
LT18.12.2019
SE18.12.2019
BG18.03.2020
NO18.03.2020
Former [2020/21]NO18.03.2020
Cited inInternational search[Y]US2007269537  (GUPTA SHYAM K [US]) [Y] 14* paragraphs [0019] - [0028] *;
 [XAY]WO2008030536  (JACQUET ROBERT J [US], et al) [X] 13,16 * claims 1-20 * [A] 1-12,15 [Y] 14;
 [XAI]  - ANNA K. KISS ET AL, "Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp", PHYTOMEDICINE, (20110501), vol. 18, no. 7, doi:10.1016/j.phymed.2010.10.016, ISSN 0944-7113, pages 557 - 560, XP055139861 [X] 2 * abstract * [A] 1,3-10 [I] 11-18

DOI:   http://dx.doi.org/10.1016/j.phymed.2010.10.016
    [XAYI] - LUCIA BATTINELLI ET AL, "Antimicrobial activity of Epilobium spp. extracts", IL FARMACO, (20010701), vol. 56, no. 5-7, doi:10.1016/S0014-827X(01)01047-3, ISSN 0014-827X, pages 345 - 348, XP055139870 [X] 1,2 * abstract * * table 1 * [A] 3-10 [Y] 14 [I] 11-18

DOI:   http://dx.doi.org/10.1016/S0014-827X(01)01047-3
    [XAYI] - B. T. HEVESI ET AL, "Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb.", PHYTOTHERAPY RESEARCH, (20090501), vol. 23, no. 5, doi:10.1002/ptr.2725, ISSN 0951-418X, pages 719 - 724, XP055140510 [X] 2 * the whole document * [A] 1,3-10 [Y] 14 [I] 11-18

DOI:   http://dx.doi.org/10.1002/ptr.2725
 [XAY]  - Anonymous, "Anti-blister Stick", GNDP, Mintel, (200811), Database accession no. 1601053, URL: www.gndp.com, XP002729787 [X] 11,13,15,16 * the whole document * [A] 1-10,12 [Y] 14
by applicantEP1767212
    - JAMES ET AL., Andrews' diseases of the skin: clinical dermatology, SAUNDERS ELSEVIER, (2006), page 308
    - SCULLY C, Oral and maxillofacial medicine: the basis of diagnosis and treatment, CHURCHILL LIVINGSTONE, (2008), pages 191 - 199
    - EGAN ET AL., AM. FAM. PHYSICIAN, (2000), vol. 62, no. 5, page 1095
    - MONIF, AM. J OBSTET. GYNECOL., (1985), vol. 152, no. 7, page 935
    - FOXMAN B, AM. J PUBLIC HEALTH, (1990), vol. 80, no. 3, page 329
    - GEIGER; FOXMAN, EPIDEMIOLOGY, (1996), vol. 7, no. 2, page 182
    - Oral and maxillofacial surgery, OXFORD UNIVERSITY PRESS, (2010), page 446,447
    - BOUQUOT ET AL., Oral & maxillofacial pathology, W.B. SAUNDERS, (2002), page 189 197
    - SAMARANAYAKE, Essential microbiology for dentistry, CHURCHILL LIVINGSTONE, (2009), pages 178 - 80,247,2
    - RHODUS, "Treatment of oral candidiasis", NORTHWEST DENTISTRY, (2012), vol. 91, no. 2, pages 32 - 3
    - ODDS, "Candida infections: an overview", CRIT. REV. MICROBIOL., (1987), vol. 15, no. 1, pages 1 - 5, XP000601010
    - CHOO ET AL., "A comparative histopathological study of systemic candidiasis in association with experimentally induced breast cancer", ONCOLOGY LETTERS, (2010), vol. 1, no. L, pages 215 - 2 2
    - ILKIT ET AL., CRITICAL REVIEWS IN MICROBIOLOGY, (2011), vol. 37, no. 3, pages 250 - 61
    - SOBEL, LANCET, (2007), vol. 369, no. 9577, pages 1961 - 71
    - BASSETTI, CRITICAL CARE, (2010), vol. 14, no. 6, page 244
    - OLLERT ET AL., INFECT. IMMUN., (1993), vol. 61, no. 11, page 4560
    - SUDBERY ET AL., TRENDS IN MICROBIOLOGY, (2004), vol. 12, no. 7, pages 317 - 324
    - BENNETT ET AL., ANNU. REV. MICROBIOL., (2005), vol. 59, pages 233 - 255
    - DENTINGER, ANN. PHARMACOTHER., (2009), vol. 43, no. 3, pages 485 - 489
    - GRUENWALD ET AL., Physician Desk Reference for herbal medicines, MEDICAL ECONOMICS COMPANY, (2007), pages 903 - 4
    - ELLEPOLA ET AL., J MICROBIOL, (2005), vol. 43, no. S, pages 65 - 84
    - AVNI ET AL., J CLIN. MICROBIOL., (2011), vol. 49, no. 2, pages 665 - 670
    - KISS ET AL., PHYTOMEDICINE, (2011), vol. 18, no. 7, pages 557 - 560
    - ACARTÜRK, RECENT PATENTS ON DRUG DELIVERY & FORMULATION, (2009), vol. 3, no. 3, pages 193 - 205
    - ASHOK ET AL., CRITICAL REVIEW IN PHARMACEUTICAL SCIENCES, (2012), vol. 1, no. 1, pages 1 - 19
    - WATSON ET AL., AUST. NNEW ZEALAND JOBSTET. GYNAECOL., (2007), vol. 47, no. 4, pages 262 - 272
    - DOUGHARI, "Phytochemicals: extraction methods, basic structures and mode of action as potential chemotherapeutic agents, phytochemicals - a global perspective of their role in nutrition and health", J CHROMATOGR. B. ANALYT. TECHNOL. BIOMEDLIFE SCI., (2012), vol. 812, no. L-2, pages 23 - 33
    - ABBET ET AL., FOOD CHEMISTRY, (2014), vol. 160, no. L, pages 165 - 170
    - DUCREY ET AL., PLANTA MED, (1997), vol. 63, no. 2, pages 111 - 114
    - SLACANIN ET AL., J CHROMATOGR, (1991), vol. 557, pages 391 - 398
    - DUCREY ET AL., PHYTOCHEMISTRY, (1995), vol. 38, no. 1, pages 129 - 137
    - Herbal drugs and Phytopharmaceuticals, MEDPHARM GMBH SCIENTIFIC PUBLISHERS, page 193
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.